Hypertonic Modulation of Inflammation Following Injury
Sponsor: University of Washington
Terminated
Enrollment in the clinical trial was stopped for futility
Other terminated trials from University of Washington
Other Hemorrhagic Shock trials with similar outcome
A observational or N/A phase clinical study on Hemorrhagic Shock and Traumatic Brain Injury, this trial is terminated or withdrawn. The trial is conducted by University of Washington and has accumulated 12 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 7 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
May 2017 — Aug 2017 [monthly]
Terminated NA
-
Feb 2017 — May 2017 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Nov 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .